Antibacterial Ions in Clay

Dead dry land and drugAntibiotic-resistant pathogens such as E. coli and methicillin-resistant Staphylococcus aureus (MRSA) have created a need for new antibacterial approaches. Research featuring one such antibacterial innovation using clay, a material used for its medicinal properties since ancient times, was reported in PLOS ONE (the journal of the Public Library of Science).

In this case, the innovation involves the antibacterial mechanism:  specific metal ions attached to the clay. Rather than taking advantage of clay’s absorption power, this study found that the effective antibacterial mechanism is the release of specific metal ions with microbiocidal properties from the clay’s surface.

Comparisons of the antibacterial effect on pathogens of similar clay samples with different levels of iron, copper, cobalt, nickel, and zinc ions demonstrate the dominant role of those ions. Variability of antibacterial strength in clay samples correlates with the clay’s chemical variability.

Now that the mechanism has been demonstrated, further research will look to standardize the composition and antibacterial efficacy of clay, and define appropriate safety precautions to avoid effects of toxic minerals that are often also present in clays. If this works out, it could lead to another point for ancient wisdom’s applicability to modern research innovations.

 

PurThreadTM Technologies Inc. is dedicated to developing proprietary antimicrobial textile technology. Our patent-pending, integration technology and fiber formulations incorporate an EPA-registered antimicrobial additive into every fiber and yarn to protect the fabric from degradation. Learn more about our antimicrobial textile technology.

PurThread also makes a range of freshness products for other markets such as the military, emergency first responders and performance athletic wear in which our next-generation technology and fiber formulations expand the high performance options available to protect fabrics from odor, mold and mildew causing bacteria.

 

 

Antimicrobial peptides and salivary proteins

Antimicrobial agents from living beings hold the promise of helping with efforts to reduce infections. Two separate research efforts indicate sufficient potential to warrant more research and, hopefully, application: One uses a genetically engineered variant of a protein found in human saliva to reduce Candida infections; the other applies the antimicrobial peptides found in fish gills to kill E. coli pathogens.

Boston University professor, Dr. Frank Oppenheim led a team that genetically engineered a variant of the human saliva protein, histatin 3, which is known to have antimicrobial—both antifungal and antibacterial—properties. The study, Anti-candidal activity of genetically engineered histatin variants with multiple functional domains, demonstrated that duplicating active functional domains in the amino acid sequence can enhance their antifungal properties. Histatin preparations have already demonstrated their effectiveness in reducing Candida infections in AIDS patients. Antibacterial and antifungal mouthwash is one possible application. Genetically enhanced histatins could also be used to address skin infections.

Researchers at Worchester Polytechnic Institute in Massachusetts hope to adapt the fish gill antimicrobial peptide to create bacteria-killing surfaces.Meanwhile, researchers at Worchester Polytechnic Institute in Massachusetts hope to adapt the fish gill antimicrobial peptide to create bacteria-killing surfaces. Such surfaces may help reduce healthcare-acquired infections. Fish have evolved powerful defenses, including the antimicrobial peptide Chrysophsin-1 to trap and kill water-borne pathogens before they enter the bloodstream. The researchers’ study, Creating Antibacterial Surfaces with the Peptide Chrysophsin-1 is part of their effort to understand the biochemical mechanics of the pathogen-trapping process.

Using two different methods to attach the peptide to silicon and gold surfaces, the researchers then measured how well the bound peptides killed E. coli, a bacterial pathogen. When the peptides were absorbed directly into the gold and silicon crystals, and thus were lying flat on the surface, they killed 34 percent of the culture’s bacteria. However, when the peptides were glued so that the peptides seemed to be standing on their ends, they killed 82 per cent of the bacteria. Next on their research agenda is to adapt the process to titanium, stainless steel, and plastic, materials that are commonly used in food preparation and healthcare.

The peptide Chrysophsin-1, found in fish gills, is being studied for its antimicrobial properties and possible role in infection reduction in healthcare settings.

 

PurThreadTM Technologies Inc. is dedicated to developing proprietary antimicrobial textile technology. Our patent-pending, integration technology and fiber formulations incorporate an EPA-registered antimicrobial additive into every fiber and yarn to protect the fabric from degradation. Learn more about our antimicrobial textile technology

PurThread also makes a range of freshness products for other markets such as the military, emergency first responders and performance athletic wear in which our next-generation technology and fiber formulations expand the high performance options available to protect fabrics from odor, mold and mildew causing bacteria.

New Treatments and Approaches to Antibiotic-Resistant Bacteria

This edition of The Dirt highlights some innovations in treating or preventing antibiotic-resistant bacteria, starting with, well, the dirt.

Hope for Drug-Resistant TB Treatment from Soil-dwelling Bacteria. A paper published in EMBO Molecular Medicine describes the results of research on pyridomycin, a compound made by the soil-dwelling bacteria Dactylosporangium fulvum. Pyridomycin may hold hope for the 500,000 people per year who are infected by Tuberculosis bacteria that do not respond to isoniazid and rifampin, the widely used first-line treatments.

Non-Antibiotic Agents Can Render MRSA and Strep Bacteria Harmless. According to Medical News Today, rather than killing the bacteria, new antivirulence drugs discovered by Menachem Shoham at Case Western Reserve University School of Medicine prevent the production of toxins that cause disease. These antivirulence drugs are potentially alternative treatments for patients suffering from antibiotic-resistant infections such as methicillin resistant Staphylococcus Aureus (MRSA) and Streptococcus pyogenes (strep).

Bacteria-Resistant Polymers. Science News reports that researchers at the University of Nottingham have discovered a new class of polymers that resist bacterial attachment. These polymers repel bacteria and prevent the formation of biofilms, the conglomeration of bacteria that protects those bacteria from antibiotics and the body’s natural defenses. The polymers hold promise for reducing infections from catheters and other medical devices.

NIH Outbreak Brings HAIs to National Attention

NIH Outbreak Brings HAIs to National AttentionThe National Institutes of Health’s (NIH) Clinical Center was open about the history of last year’s outbreak of Klebsiella pneumoniae, an antibiotic-resistant bacteria, despite their best efforts to prevent and contain it. That openness brought healthcare acquired infections (HAIs) and the issues of antibiotic use and development into the national media.

NPR’s Diane Rehm show on Tuesday, August 28th did a good job of summarizing the issues:

  • Increasing use of antibiotics creates more antibiotic-resistant bacteria, like the one that caused the NIH outbreak.
  • Widespread use of antibiotics in animals, to promote growth, exacerbates the resistance to antibiotics in organisms.
  • Some doctors start treatment with a more broad-based antibiotic than the situation requires.
  • And the relatively short term in which people need to take antibiotics makes it less attractive or profitable for pharmaceutical companies to develop the new antibiotics we need to keep up with adaptive resistant bacteria.

One of the show’s guests made a comment that could be construed to mean that human error and the inevitability of people shortcutting the protocols are what prevent us from stopping the spread of a rampant infection. Dr. Michael Bell of the Centers for Disease Control said, “we can stamp out these infections very, very effectively. Once you detect, you protect. The problem is that people cheat. It’s very, very tempting, when you’re very busy and trying to do a lot of things for a lot of patients, to cuddle to a corner, to slip into a room without putting on a gown, slip back out. And when that happens, that opens a pathway for the organism to be carried to yet another patient.” Unfortunately, the NIH case disproves that idea.

That outbreak took place at one of the most advanced and specialized hospitals in the country. The hospital took all the right precautions of isolation, education, hygiene, and environmental service protocols, and even had personnel to monitor compliance to those procedures. And yet new cases of infection arose weekly. Clearly, handwashing and those other protocols are essential to controlling infection. However, by themselves, they’re not sufficient to the task.

Healthcare-acquired infections are a complex problem that will require ongoing and multi-faceted effort: careful antibiotic stewardship, hygiene and environmental service protocols, hard and soft surface management, ventilation and education—of medical personnel, patients, and the public—must work in concert to prevent and control infections.

PurThread: Textile World’s Quality Fabric of the Month

PurThread: Textile World’s Quality Fabric of the MonthWe were honored by Textile World’s coverage this month. The article did a good job of summarizing the reason we are developing this fiber technology. Healthcare-acquired infections (HAIs) are a significant problem that kill almost 100,000 people each year in the US alone. Sadly as was seen in the recent stories about the 2011 superbug outbreak at NIH, hand hygiene and other current practices are insufficient to the challenge. We are developing continuously active fabrics based on proprietary integration technology and a complex element compound. Once these textiles complete a thorough government review, PurThread will introduce privacy curtains, scrubs, bed linens and other fabric products used in healthcare facilities with the goal of reducing bioburden on these soft surfaces, helping to break the chain of pathogen transmission from those surfaces to healthcare worker hands that all too frequently form the bus network delivering pathogens to patients.

The article refers to both the study showing that 92 percent of traditional hospital privacy curtains became contaminated within one week of being laundered, and an upcoming peer-reviewed study of the efficacy of PurThread privacy curtains in reducing bioburden on the curtains themselves. In developing these products we are focusing not only on delivering fabric surfaces that will make a measurable difference in tough clinical settings, but also on making fabrics that have a soft, comfortable feel and that require no special handling or laundry protocols.

We extend our thanks to Textile World for the recognition.